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Background: Anecdotal and clinical theories purport that females are more responsive to smoking cues, yet few
objective, neurophysiological examinations of these theories have been conducted. The current study examines the
impact of sex on brain responses to smoking cues.
Methods: Fifty-one (31 males) cigarette-dependent sated smokers underwent pseudo-continuous arterial spin-
labeled perfusion functional magnetic resonance imaging during exposure to visual smoking cues and non-
smoking cues. Brain responses to smoking cues relative to non-smoking cues were examined within males and
females separately and then compared between males and females. Cigarettes smoked per day was included in
analyses as a covariate.
Results: Both males and females showed increased responses to smoking cues compared to non-smoking cues
with males exhibiting increased medial orbitofrontal cortex and ventral striatum/ventral pallidum responses, and
females showing increased medial orbitofrontal cortex responses. Direct comparisons between male and female
brain responses revealed that males showed greater bilateral hippocampal/amygdala activation to smoking cues
relative to non-smoking cues.
Conclusions: Males and females exhibit similar responses to smoking cues relative to non-smoking cues in a priori
reward-related regions; however, direct comparisons between sexes indicate that smoking cues evoke greater
bilateral hippocampal/amygdalar activation among males. Given the current literature on sex differences in smoking
cue neural activity is sparse and incomplete, these results contribute to our knowledge of the neurobiological
underpinnings of drug cue reactivity.
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Smoking cessation treatments are efficacious in some
smokers, but overall treatment success is modest
(20-40%), reflecting heterogeneity in treatment response
[1]. In an attempt to improve cessation outcomes, re-
search has started to focus on individual differences that
contribute to cigarette smoking behavior and treatment
response. One factor that may influence smoking main-
tenance and treatment outcome is the smoker’s sex. Al-
though smoking rates have declined over the past
40 years, the rate of decline among women has been less* Correspondence: rweth@mail.med.upenn.edu
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reproduction in any medium, provided the orthan the rate of decline among men (20% compared to
30%, respectively; [2]). The mechanisms underlying why
women have lower rates of cessation than men remain
unknown; however, some research suggests that sex differ-
ences in responses to nicotine and non-nicotine factors
may influence smoking cessation outcomes [3,4].
Both preclinical and clinical literature indicate that once
nicotine/cigarette dependence is established, smoking be-
havior in males may be influenced more by maintaining
nicotine levels in the brain; whereas, female smoking
behavior may be influenced more by non-nicotine fac-
tors, such as smoking-related stimuli (i.e., smoking cues
(SCs)) (for a review see [5]). For example, males are
more accurate at discriminating variations in the
amount of nicotine in cigarettes and spray than femalesal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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forcement relative to males, as measured by cigarette
puffs, when exposed to a lit cigarette cue [8]. In a subse-
quent study, Perkins and colleagues found that females
showed decreased ad lib puff self-administration and
hedonic ratings of puff self-administration relative to
males when olfactory and gustatory SCs were blocked (i.e.,
blocking nostrils while smoking cigarettes via nose-clips)
[9]. In other work, it was shown that females received
more craving relief from smoking a denicotinized
cigarette than males [10]. Together, these findings sug-
gest that non-nicotinic aspects of smoking influence
females’ smoking behavior more than males.
The picture becomes less clear in studies examining
the impact of sex on physiological and subjective re-
sponses to SCs [11-14]. In some studies, females
reported higher SC-induced subjective craving and
showed greater changes in mean arterial pressure than
males [11,13], yet Tong and colleagues [12] found that
males had higher blood pressure and skin temperature
responses to SCs than females. Other studies, however,
reported no sex differences in physiological or subject-
ive reports of craving [14,15]. While these inconsistent
findings may be related to methodological differences
between studies, they may also be related to caveats as-
sociated with self-report and physiological assessments.
Thus, the current study uses an objective, neurobio-
logical approach to examine the impact of sex on brain
responses to SCs.
Previous neuroimaging studies examining neural re-
sponses to SCs have consistently shown robust brain
responses to SCs in reward-related mesocorticolimbic
circuitry (medial orbitofrontal cortex (mOFC), ventral
striatum/ventral pallidum (VS/VP), hippocampus, amyg-
dala, and insula) [16-19]. Although cigarette-dependent
smokers exhibit characteristic neural responses to SCs,
the impact of sex on neural responses to SCs remains
largely unexplored. One functional magnetic resonance
imaging (fMRI) study found that females exhibited SC-
induced brain responses in the cuneus and superior
temporal gyrus, while males showed brain responses in
hippocampus and orbitofrontal cortex [20]; however, sam-
ple size was small (females: n = 7) and direct comparisons
of SC-induced brain responses between females and males
were not explored. In fact, no neuroimaging studies to
date have directly compared male and female brain
responses to SCs.
To this end, the current study directly investigated the
effects of sex on brain responses to SCs. Given that males
and females respond differently to nicotine and nicotine-
related factors, we hypothesized that they would also show
differences in brain responses during SC exposure. Based
on previous research suggesting greater behavioral and
physiological responses to SCs among females relative tomales [8,9,11,13], we hypothesized that females would
show greater brain responses to SCs than males in brain
regions that we have consistently shown to be associated
with SC-reactivity (i.e., mOFC, VS/VP, hippocampus,
amygdala, and insula) [16,21-23]. To test this hypothesis,
we used the technique of pseudo-continuous arterial
spin-labeled (pCASL) perfusion fMRI to acquire brain
responses during SC (versus non-SC) exposure.
Methods
Participants
Participants were recruited via radio advertisements and
local list-serves describing a study for smokers contem-
plating quitting, but not ready to quit. Telephone screens,
as well as medical and psychiatric evaluations were used
to determine participant eligibility. Ineligible participants
were those who reported other current substance depend-
ence, had current Axis I DSM IV psychiatric diagnoses,
had significant medical conditions, reported a history of
head trauma or injury causing loss of consciousness last-
ing greater than three minutes or associated with skull
fracture or intracranial bleeding, or had irremovable mag-
netically active objects on or within their body. All eligible
and interested participants provided informed consent
prior to their inclusion in the study.
Fifty-one physically healthy smokers (31 males) ranging
in age from 18 to 58 years (34.2 ± 11.5) participated in the
study. The sample is comprised of 69% Caucasians, 22%
African Americans, and 9% Other/Mixed race. Perfu-
sion fMRI data from these participants were previously
reported in a study examining genetic influences on SC
responses [23]. Following consent, participants com-
pleted psychological and physical evaluations. Partici-
pants received $100.00 for completing the study. The
study adhered to the Declaration of Helsinki and was
approved by the University of Pennsylvania Institutional
Review Board.
Measures
The MINI International Neuropsychiatric Interview [24]
assessed current DSM-IV diagnosis of substance depend-
ence other than nicotine and current severe psychiatric
symptoms. The Fagerstrom Test for Nicotine Dependence
(FTND) [25] assessed severity of nicotine dependence.
The Craving and Withdrawal Questionnaire (CWQ)
measured subjective ratings of craving, withdrawal,
mood state, and interest in the video before and after
stimulus presentations during the scan session.
Imaging approach
Pseudo-continuous arterial spin-labeled (pCASL) perfu-
sion fMRI, a quantitative estimate of cerebral blood flow
(CBF) and indirect measurement of neural activity [26],
assessed brain activation in response to SC exposure.
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to minimize nicotine withdrawal-induced craving that
might accrue during the scanning session. Scanning oc-
curred approximately 25 minutes after smoking to allow
the acute cardiovascular effects of smoking to dissipate.
During each scanning session, participants completed, in
sequence, a five minute resting baseline scan; a 10 minute
non-SC pCASL scan; a high resolution structural scan;
and a 10 minute SC pCASL scan.
Ten-minute audio-visual clips were presented during
pCASL scanning. The SC video included individuals dif-
fering in race, age, and sex who were smoking and using
explicit language designed to induce appetitive desire for
a cigarette. The non-SC video was similar in content;
however, the video did not portray cigarette smoking or
smoking reminders. The non-SC video was shown be-
fore the SC video to minimize interference in ‘carryover’
arousal initiated when drug cues are shown first, which
can potentially affect responses to nondrug cues [27-29].
Imaging data acquisition
Imaging data were acquired on a 3.0 Tesla Trio whole-
body scanner (Siemens AG, Erlangen, Germany) using a
Bruker volume coil (volume coils are designed to pro-
vide a homogenous receiving sensitivity and are 1 chan-
nel; Bruker Biospin, Billerica, MA) for 19 subjects and a
standard 8-channel receive-only array head coil for the
remaining 32 subjects. For co-registration of the func-
tional data, a T1-weighted three-dimensional (3D) high
resolution MPRAGE scan was acquired with field of view
(FOV) = 160 mm, repetition time (TR) = 1510 ms, echo
time (TE) = 3 ms, 192 × 256 matrix, slice thickness 1 mm
for 19 subjects and FOV= 250 mm, TR/TE = 1620/3 ms,
192 × 256 matrix, slice thickness 1 mm for the remaining
32 subjects. pCASL perfusion fMRI sequence was used for
resting baseline, SC and non-SC data acquisition. Inter-
leaved images with and without labeling were obtained
using a gradient echo echo-planar imaging sequence with
a delay of 1000 ms for 19 subjects or 700 ms for 32
subjects inserted between the end of the labeling pulse
and image acquisition (FOV = 130 mm, matrix = 64 ×
64 × 14, TR/TE = 3000/17 ms, flip angle = 90°, slice
thickness = 6 mm with a 2 mm inter-slice gap for 32
subjects and a 1.2 mm inter-slice gap for 19 subjects.
Imaging data processing and statistical analyses
An SPM-based arterial spin labeling (ASL) data process-
ing toolbox [30] was used for pCASL perfusion data ana-
lyses, as described previously [21,22]. Briefly, ASL image
pairs were realigned to the mean of all control images
and spatially smoothed with a 3D isotropic Gaussian
kernel at 10 mm full width at half maximum (FWHM).
For both SC and non-SC stimuli, 100 CBF image series
were generated from the 100 label/control ASL imagepairs using a simplified two-compartment model with
the sinc interpolation method for CBF calculations [31].
For resting baseline (RB), 48 CBF image series were gen-
erated from the 48/label/control ASL image pairs using
the same methods for CBF calculations. The mean con-
trol image of each subject’s data was co-registered to the
structural image using the mutual information based co-
registration algorithm provided by SPM8. The same
transformation parameters were applied to co-register
the CBF maps to each subject's anatomical image. Sub-
sequently, the structural image was spatially normalized
to the Montreal Neurological Institute (MNI) standard
brain. The resulting transformation matrix was used to
align the CBF images to MNI space. A binary brain
mask was used to exclude the non-brain areas in the
CBF maps.
Contrasts between SC versus non-SC sets were defined
in the general linear model (GLM) model to assess the
voxel by voxel CBF difference for each subject. Using the
corresponding parametric maps of the contrast, random
effects analysis was employed to test for a significant main
effect of condition (SC versus non-SC) in each sex with a
statistical parametric map of the T-statistic at each voxel for
population inference within our regions of interest (ROI)
mask. Based on our previous studies on SC-reactivity
among cigarette-dependent smokers [16,21-23], the ROI
mask included the mOFC, VS/VP, hippocampus, extended
amygdala (i.e., amygdala; bed nucleus of stria terminalis
(BNST)), anterior cingulate cortex (ACC), and insula. The
ROI mask was created using the Harvard–Oxford prob-
abilistic anatomical atlas provided with FMRIB Software
Library (FSL) [32] and is available for viewing at http://
franklinbrainimaging.com/. Significant voxels passed a
voxelwise statistical threshold (p < 0.005) and, to control
for multiple comparisons, were required to be part of a
cluster > 54 voxels, as determined by a Monte-Carlo
simulation and resulted in 5% probability (corrected) of
a cluster surviving due to chance. Brain and behavioral
correlates were examined using linear regression ana-
lyses for each sex using change in craving scores to SCs
and brain activity at each voxel within the ROI mask.
Post hoc analyses
Post hoc analyses examined potential sex differences in
resting baseline by extracting CBF from the significant
functional clusters within the ROI mask wherein SCs
elicited greater neural activity (i.e., mOFC, VS/VP, and
hippocampus/amygdala). The average quantitative CBF
values (ml of blood/100 g of tissue/minute) was com-
puted for females and males and then compared with in-
dependent samples t-tests. Additional post hoc analyses
examined sex differences in brain responses to non-SCs
to determine whether females and males differed in
brain responses to visual cues, in general. This analysis
Table 1 Participant characteristics
All Males Females p
N = 51 n = 31 n = 20
Race (%)
White 35 (69) 22 (71) 13 (65) 0.60
Black 11 (22) 7 (23) 4 (20)
Other 5 (9) 2 (6) 3 (15)
Means ± (SEMs)
Age 34.2 (1.6) 36.2 (2.0) 30.9 (2.5) 0.10
Education 14.4 (0.3) 14.3 (0.3) 14.7 (0.6) 0.52
Cigarettes per day 15.6 (0.8) 16.9 (1.0) 13.6 (1.2) 0.04*
Pack yearsa 12.5 (1.6) 15.2 (2.4) 8.4 (1.6) 0.04*
FTND scores 4.5 (0.2) 4.7 (0.3) 4.3 (0.5) 0.44
Craving scoresb 0.8 (0.2) 0.8 (0.3) 0.9 (0.4) 0.93
* p < 0.05.
aPack years calculation: Cigarettes per day (÷) cigarettes in a pack (X)
years smoking.
bCraving scores calculation: Post-SC video craving score – Pre-SC video
craving score.
FTND = Fagerstrom Test for Nicotine Dependence; FTND scores ranged from 1
to 9.
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scribed above; however, the analysis used an exploratory
whole-brain approach and the non-SC versus resting
baseline contrast was used rather than the SC versus
non-SC contrast.
Covariates
Consistent with recent national survey data indicating
higher rates of cigarette use among males than females
[33], males in the current study smoked more cigarettes
per day than females. Therefore, the cigarettes smoked
per day variable was included in analyses as a covariate.
Demographic and behavioral statistical analyses
Continuous demographic variables were summarized,
by calculating means and standard error measurements
(X ± SEMs). For the CWQ data, change scores were cal-
culated as follows: post-SC video score – pre-SC video
score. Independent samples t-tests compared females and
males on continuous variables. Nominal demographic var-
iables were summarized by calculating proportions and
compared across groups using chi-square analyses. A re-
peated measures analysis of variance (ANOVA) with time
(i.e., pre- and post-SC ratings) as the within-subjects factor
and sex (i.e., male or female) as the between subject factor
was used to determine the effects of SC exposure on sub-
jective ratings of craving, feeling calm, feeling content, and
the need to smoke a cigarette for relief.
Results
Participant characteristics
Table 1 provides participant demographics and smoking
history characteristics. There were no significant sex
differences in years of education, age, race, number of
years smoking, or FTND scores (ps > 0.10). Sex differ-
ences emerged for cigarettes smoked per day, t(49) =
2.12, p = 0.04) and pack years (a measure to quantify
intensity of chronic cigarette exposure since smoking
initiation), t(49) = 2.11, p = 0.04, with males having
higher values on these measures than females. Partici-
pants smoked 15.6 ± 0.8 cigarettes per day, and FTND
scores were 4.5 ± 0.2, indicating moderate nicotine
dependence.
Subjective ratings
A repeated measures ANOVA revealed main effects of time
(F1,49 = 23.79, p < 0.001, η
2 = 0.33) and sex (F1,49 = 5.89,
p = 0.02, η2 = 0.11) with an overall increase in subjective
reports of craving for a cigarette following exposure to
SCs and females reporting greater craving than males.
Time x Sex interaction was not significant (p = 0.94) indi-
cating similar increases in craving following SC exposure
for females and males (Table 2-item 3). There was a
significant main effect of time (F1,49 = 14.63, p < 0.001,η2 = 0.23) in subjective reports of a need to smoke for
relief following exposure to SCs with overall increases
in the need to smoke for relief following SC exposure.
The main effect of gender and the Time x Sex inter-
action were not significant. No significant main effects
or interactions emerged for the other items of the
CWQ, which assessed the extent to which the partici-
pant felt calm and content. An independent t-test ex-
amined sex differences in interest in the SC video and
revealed no significant differences (p = 0.97) (Table 2).
Imaging results
Smoking cue reactivity in males and females
Males and female sated-smokers exhibited similar brain
responses to SCs relative to non-SCs, with males
exhibiting greater activity in mOFC and VS/VP regions
and females showing enhanced activity in the mOFC.
Comparisons between groups revealed significant sex dif-
ferences with males exhibiting greater SC-induced brain
activity in bilateral clusters spanning hippocampal and
amygdalar regions compared with females (Figures 1, 2).
An interactive visual display of all brain data and unmasked
data at a reduced threshold can be found at http://
franklinbrainimaging.com.
Brain and craving score correlates by sex
Using a corrected voxelwise statistical threshold (p < 0.005
and cluster size > 54), analyses revealed that SC-elicited
craving scores (post-SC video – pre-SC video) did not
correlate with SC-induced brain activity for males or
females. Overall craving scores (pre- or post-SC video)
also did not correlate.
Table 2 Craving and withdrawal questionnaire items
Females Males p
1) How calm are you right now? −0.15 ± 0.99 0.00 ± 1.32 0.67
2) How content do you feel right now? 0.15 ± 0.99 −0.16 ± 0.93 0.26
3) How much do you desire a cigarette right now? 1.00 ± 1.81 0.97 ± 1.08 0.94
4) How much do you need to smoke right now for relief? 0.55 ± 1.67 1.03 ± 1.28 0.25
5) How interested were you in the video you just watched? 3.40 ± 1.88 3.42 ± 1.95 0.97
For items 1–7, scores were generated from the difference between pre-smoking cue exposure to post-smoking cue exposure. Each item was inserted into the
phrase “On a scale from 1 to 7….. with 1 corresponding to Not at all and 7 corresponding to Extremely”.
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Given that direct comparisons between males and fe-
males revealed that males exhibited greater responses to
SCs in the hippocampus/amygdala compared with fe-
males and this finding is in opposition to our hypoth-
esis, we hypothesized that higher resting baseline CBF
in females may be interfering with the ability to capture
SC-induced signal. Thus, in post hoc analyses, CBF
values were extracted from the functional ROIs wherein
SCs elicited greater activity than non-SCs (i.e., VS,
mOFC and hippocampus/amygdala). Females had signifi-
cantly greater resting baseline CBF than males in the VS
(50.59 ml of blood/100 g of tissue/minute in females versus
40.94 ml blood/100 g tissue/min in males; p = 0.01) and the
mOFC (68.50 ml blood/100 g tissue/min in females versus
53.82 ml blood/100 g tissue/min in males; p = 0.001), butFigure 1 Brain responses to smoking cues relative to non-smoking cu
cortex (mOFC), for males crosshairs are centered on the ventral striatum (V
are centered on the left hippocampus/amygdala (H-A). Representative fMR
on the MNI brain. T values range from 3.10 to 4.19, corrected at p < 0.005. I
display of all brain data in all three planes can be found at http://franklinbrfemales and males did not differ in resting baseline CBF in
the hippocampus/amygdala (55.57 ml blood/100 g tissue/
min in females versus 50.40 ml blood/100 g tissue/min in
males; p = 0.174). These values were then entered into the
SC vs non-SC contrast as covariates to determine whether
SC results were obscured, facilitated or independent of rest-
ing baseline CBF. Results were unchanged in all analyses
(Males: VS and mOFC; Females: mOFC; and Males vs Fe-
males: bilateral hippocampus/amygdala).
In an attempt to shed light on potential mechanisms
underlying the impact of sex on brain responses to SCs,
additional exploratory post hoc analyses examined sex
differences in brain responses to non-SCs to determine
whether females and males differed in brain responses
to visual cues in general. No differences between groups
were observed.es. For females crosshairs are centered on the medial orbitofrontal
S), and for direct comparisons between males and females crosshairs
I sagittal, axial, and coronal brain slices analyzed in SPM8 and overlain
mages are displayed neurologically (left is left). An interactive visual
ainimaging.com.
Figure 2 Cerebral blood flow in the left hippocampus/amygdala during smoking cue exposure. Cerebral blood flow in the left
hippocampus/amygdala (H-A) during smoking cue exposure in male and female smokers. Cerebral blood flow =ml of blood/100 g of tissue/
minute.
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To our knowledge, this is the first neuroimaging study
to directly examine sex differences in brain responses to
SCs by explicitly comparing male and female brain activity
to SCs relative to non-SCs. As expected, both male and
female sated-smokers showed greater brain activation to
SCs relative to non-SCs. Males exhibited SC-induced brain
activity in the mOFC and VS/VP, and females showed acti-
vation in the mOFC. We also hypothesized that females
would show greater brain responses to SCs than males;
however, direct comparisons revealed that males showed
greater SC-induced brain activity than females in bilateral
clusters spanning hippocampal/amygdala regions.
We observed increased brain activity to SC vs non-SCs
in the mOFC of male and female smokers and increased
neural activity to SCs in the VS/VP among males. These
findings are analogous to our earlier studies showing
mOFC and VS/VP activity in response to SCs [16,21,22].
The mOFC and VS/VP are functionally related regions
involved in the processing of the incentive salience of
rewards and reward-related cues [34]. Specifically, the
mOFC has been consistently implicated in reward pro-
cesses [35,36], and as such, it is not surprising that SCs
evoke greater mOFC responses than non-SCs among
smokers. Males also showed enhanced brain activity to
SCs in the VS/VP. Neuroimaging evidence suggests that
the VS/VP is associated with reward anticipation [37],
subsequent reward-related behavior [38], and reward
consumption [39]. Enhanced VS/VP activity during SC-
relative to non-SC exposure perhaps suggests that viewing
SCs evoked greater anticipation and reward than viewing
non-SCs. Of note, females also showed increased VSresponse to SCs relative to non-SCs at a more liberal
threshold (see http://franklinbrainimaging.com), but this
increased activation did not reach significance using our
conservative analytic approach.
Although males and females showed reward-related ac-
tivation to SCs, direct comparisons between SC-induced
brain responses revealed sex-specific differences. Males
exhibited greater brain responses to SCs in bilateral clus-
ters spanning portions of the hippocampus and amygdala,
but there were no areas in which females showed greater
brain responses to SCs relative to males. The hippocam-
pus and amygdala are structures associated with emotional
and drug memories [40,41], and as such, our findings may
be explained by memory-related sex differences evoked
during the 10-minute smoking cue video. Specifically, re-
search indicates that females recall personally experienced
events (i.e., autobiographical memories) faster and bet-
ter than males, especially when those memories are
emotionally relevant [42,43]. In other words, females
appear to be more efficient at retrieving autobiograph-
ical memories, and therefore, males may require greater
memory-related, hippocampal-amygdalar brain activity
when retrieving cue-associated memories. Although this
interpretation is speculative and an abductive inference,
recent evidence reporting that males show greater hip-
pocampal activation than females when recalling auto-
biographical memory, such as smoking a cigarette,
supports this interpretation [44].
This differential finding may also be partially explained
by variations in menstrual cycle phase/circulating gonadal
hormones (e.g., estradiol and progesterone) among female
participants. Preclinical and clinical evidence indicates that
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role in reward-related brain and behavioral responses in
females [45,46]. Women in the luteal phase demonstrate
differential activation in brain regions involved in the
response to reward (e.g., OFC, VS, insula, hippocampus,
amygdala) during reward-related tasks as compared to
women in the follicular phase [46,47]. Further, circulat-
ing levels of estrogen and progesterone, which vary
throughout the menstrual cycle, correlate with brain ac-
tivity in these regions [47]. Consequently, cyclic changes
in neural responsiveness due to menstrual cycle phase/
circulating gonadal hormones may influence sex differ-
ences in mesocorticolimbic brain activity. Indeed, in a re-
cent neuroimaging study that examined neural activity in
response to negative visual stimuli, no significant differ-
ences in brain activity were noted between males and
females when females were scanned in the early follicular
phase; however, differences emerged in reward-related
brain regions between males and these same females when
they were scanned around the time of ovulation [48].
Collectively, these studies indicate that menstrual cycle
phase may influence the impact of sex on brain response
to visual cues.
Correlative relationships between brain response and
craving were not observed. One contributing factor may
be the stringent thresholding criteria utilized in this
study. Another contributing factor could be variations in
how participants labeled their craving. Subjective reports
of craving in drug-dependent populations are fraught
with caveats, including difficulty in labeling emotions
[49]. Indeed, several studies demonstrating correlations
between craving induced by drug cues and brain activity
are often in opposition [16,18,21,22,50] or have not been
observed [51-54]. The findings reported here and the
lack of agreement among myriad studies highlight the
limitations associated with subjective measures and en-
courage the use of objective markers.
The current findings should be interpreted in light of
the following limitations. A potential confound in our
findings could be due to differences in data acquisition.
For example, the first 19 subjects were scanned using a
Bruker coil; whereas, the remaining subjects were scanned
using an 8-channel coil. To explore whether data acquisi-
tion differences affected findings, we compared variances
between both groups using a homogeneity of variance test
and found that the variances were not significantly dif-
ferent. This study is also limited in that we focused
solely on sex differences in brain responses to SCs. We
recognize that many factors are at play, including men-
strual cycle, negative affect/mood, stress, and variance
in genes [22,55-57]. Specifically, in our lab we have
found and confirmed a robust effect of dopamine trans-
porter genotype on neural responses to SCs [21,22]. We
are confident the results reported here are unrelated todopamine transporter genotype because there is equiva-
lent representation of the variants between males and
females. As noted above, we also have evidence-based
hypotheses regarding the role of menstrual cycle phase/
gonadal hormones on female response to SCs. To date,
however, our sample sizes are insufficient to assess the
influence of menstrual cycle phase/gonadal hormones.
Of the 20 female participants, 10 females were taking
oral contraceptives, two were postmenopausal, six were
in the follicular phase, and two were in the luteal phase.
We continue to acquire data in order to obtain sample
sizes that are sufficient to assess this, as well as the main
effects and interactions of other factors on relapse
vulnerabilities.
Conclusions
In summary, anecdotal and clinical theories purport that
females are more responsive to SCs, yet few objective,
neurophysiological examinations of these theories have
been conducted. The current study is the first neuroimag-
ing study to directly compare male and female brain re-
sponses to SCs. Overall, male and female sated-smokers
showed similar activation to SCs, with males showing
greater brain activity in the mOFC and VS/VP during SC
exposure relative to non-SC exposure, and females
exhibiting greater activation in the mOFC. Direct compar-
isons between male and female brain responses to SCs
relative to non-SCs revealed that males showed greater
bilateral hippocampal/amygdalar activation to SCs than
females, which may be explained by sex differences in
memory processes elicited by cue exposure and variations
in menstrual cycle phase/circulating gonadal hormones.
The primary findings of SC reactivity modulated by sex, in
a priori reward-related regions supported by both clinical
and preclinical studies, has been underexplored, and thus,
the findings contribute to our knowledge of the neuro-
biological underpinnings of drug cue reactivity.
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